Chitosan-based systems aimed at local application for vaginal infections.

Area of Science:

• Biomedical Engineering
• Polymer Science
• Pharmacology

Background:

• Vaginal drug administration offers advantages for treating local infections by bypassing systemic effects.
• Current topical treatments for vulvovaginal conditions have limited patient acceptance and suboptimal drug delivery.
• Mucoadhesive systems can prolong drug residence time in the vaginal tract, enhancing therapeutic outcomes.

Purpose of the Study:

• To review studies utilizing chitosan for developing mucoadhesive systems for vaginal infection treatment.
• To evaluate the potential of chitosan-based mucoadhesive drug delivery systems (DDS) in managing local vaginal diseases.

Main Methods:

• Systematic review of scientific literature focusing on chitosan-based mucoadhesive systems for vaginal applications.
• Analysis of studies investigating the formulation, characterization, and efficacy of these systems.

Main Results:

• Chitosan is a biocompatible and versatile polymer suitable for creating mucoadhesive drug delivery systems (DDS).
• Chitosan-based mucoadhesive systems demonstrate enhanced drug retention in the vaginal environment.
• Chitosan exhibits intrinsic antimicrobial activity and does not negatively impact the efficacy of co-administered antimicrobial agents.

Conclusions:

• Chitosan-based mucoadhesive systems represent a promising strategy for the local treatment of vaginal infectious diseases.
• The dual action of enhanced drug delivery and inherent antimicrobial properties makes chitosan a valuable biopolymer for vaginal therapeutics.
• Further development of these systems could lead to improved patient compliance and treatment effectiveness for vaginal infections.